Handelsbanken Fonder AB »

Denali Therapeutics shares owned by Handelsbanken Fonder AB

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Handelsbanken Fonder AB from 13F filings

Historical chart of Handelsbanken Fonder AB investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Handelsbanken Fonder AB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Handelsbanken Fonder AB

Quarter filed Position value Share count Share price at filing
2025-09-30 $556k 38k 14.52
2025-06-30 $536k 38k 13.99
2025-03-31 $521k 38k 13.60
2024-12-31 $781k 38k 20.39
2024-09-30 $1.2M 40k 29.14
2024-06-30 $917k 40k 23.22
2024-03-31 $490k 24k 20.50
2023-12-31 $513k 24k 21.46
2023-09-30 $355k 17k 20.64
2023-06-30 $508k 17k 29.53
2023-03-31 $325k 14k 23.05
2022-12-31 $392k 14k 27.80
2022-09-30 $411k 13k 30.67
2022-06-30 $394k 13k 29.40
2022-03-31 $380k 12k 32.20
2021-12-31 $803k 18k 44.61
2021-09-30 $908k 18k 50.44
2021-06-30 $1.4M 18k 78.44
2021-03-31 $1.0M 18k 57.09
2020-12-31 $1.2M 14k 83.76
2020-09-30 $505k 14k 35.82
2020-06-30 $341k 14k 24.18